论文信息 - A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion. - 字舞流文

A phase I study of the antimetabolite (E)-2'-fluoromethylene-2'-deoxycytidine (MDL 101,731) administered as a twice-weekly infusion.

V. Devita | B. Burtness | J. Marsh | K. Peccerillo | G. Pizzorno | A. McKeon | M. Clark | J. Winship | M. Stoltz | L. Lamb | M. Belker | S. Chmael